Skip to main content
Yanjiu Conference logo

Call for Papers – ICCMDB 2027, Las Vegas

International Conference on CRISPR Molecular Diagnostics and Biosensing — ICCMDB 2027

Dates

20–21 March 2027

Venue

Las Vegas, USA

Field

CRISPR Molecular Diagnostics and Biosensing

Topics of ICCMDB 2027

Original papers are invited in CRISPR Molecular Diagnostics and Biosensing. Submit by 16 February 2027.

Submit Your Paper

Topics include, but are not limited to:

Diagnostic Applications of CRISPR

  • CRISPR-based assays in infectious disease detection.
  • Innovations in rapid CRISPR diagnostics.
  • Integration of CRISPR with point-of-care testing.

Biosensing Technologies

  • Development of CRISPR biosensors for biomarker detection.
  • Nanomaterial enhancements in CRISPR biosensing.
  • Comparative analysis of CRISPR and traditional biosensing.

CRISPR Editing Techniques

  • Novel CRISPR systems for precise genetic modifications.
  • Optimizing target specificity in diagnostics.
  • Challenges in the use of CRISPR for gene editing in diagnostics.

Regulatory and Ethical Considerations

  • Ethical implications of CRISPR diagnostics in healthcare.
  • Regulatory frameworks for CRISPR technologies.
  • Public perceptions of CRISPR applications in diagnostics.

Interdisciplinary Collaborations

  • Collaboration between biologists and engineers.
  • Role of data science in CRISPR diagnostics.
  • Building partnerships for technology transfer in biosensing.

Important Dates

Conference opens in

00days
00hours
00min
00sec
  1. Step 1

    Submission Deadline

  2. Step 2

    Registration Deadline

  3. Step 3

    Conference Date

Download

Get the official templates and forms for ICCMDB 2027. Use the latest versions when preparing your submission.

Peer Review Process

Follow each step from abstract submission to awards and recognition.

Yanjiuconference peer review process: 12 steps from abstract submission to awards and recognition

See You in Las Vegas This March

Present your research, meet peers from over 50 countries and help shape the future of CRISPR Molecular Diagnostics and Biosensing.